CD8A and cancer: However, implantation of SCCVII expressing EGFRvIII significantly boosted the EGFRvIII-specific CD8+ T cell responses (Fig 5AII), indicating that the T cells generated by vaccination further expanded following recognition of antigens present in the cancer cells.